logo
Plus   Neg
Share
Email

Builders FirstSource Q1 Loss Narrows

Builders FirstSource Inc. (BLDR) Thursday said its first-quarter loss narrowed from last year, despite a 35 percent revenue growth.

First-quarter loss narrowed to $19.1 million or $0.20 per share from $21.1 million or $0.22 per share in the year-earlier period.

Adjusted net loss from continuing operations was $10 million or $0.11 per share, compared to $12.5 million or $0.13 per share last year. On average, three analysts polled by Thomson Reuters expected the company to lose $0.14 per share in the first quarter. Analysts' estimates typically exclude special items.

Net revenue totaled $219.4 million, up 34.7 percent from $162.8 million last year. Analysts expected revenues of $190.67 million.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT